A citation-based method for searching scientific literature

F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel, Wallace Akerley, Alfons J M van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia M Vaubel, Gerald P Linette, David Hogg, Christian H Ottensmeier, Celeste Lebbé, Christian Peschel, Ian Quirt, Joseph I Clark, Jedd D Wolchok, Jeffrey S Weber, Jason Tian, Michael J Yellin, Geoffrey M Nichol, Axel Hoos, Walter J Urba. N Engl J Med 2010
Times Cited: 9840



Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins, Philip D Leming, David R Spigel, Scott J Antonia, Leora Horn, Charles G Drake, Drew M Pardoll, Lieping Chen, William H Sharfman, Robert A Anders, Janis M Taube, Tracee L McMiller, Haiying Xu, Alan J Korman, Maria Jure-Kunkel, Shruti Agrawal, Daniel McDonald, Georgia D Kollia, Ashok Gupta, Jon M Wigginton, Mario Sznol. N Engl J Med 2012
Times Cited: 8213




List of shared articles



Times cited

Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle.
Qianqian Li, Zhaoqing Shi, Fan Zhang, Weiwei Zeng, Dunwan Zhu, Lin Mei. Acta Pharm Sin B 2022
2

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.
Haixia Long, Qingzhu Jia, Liuyang Wang, Wenfeng Fang, Zhongyu Wang, Tao Jiang, Fei Zhou, Zheng Jin, Jiani Huang, Li Zhou,[...]. Cancer Cell 2022
0

Immune checkpoint inhibition in patients with inactive pre-existing neuromuscular autoimmune diseases.
Andrew Snavely, Eduardo J Pérez-Torres, Jeffrey S Weber, Sabina Sandigursky, Sujata P Thawani. J Neurol Sci 2022
0

Perspectives on the role of breast cancer susceptibility gene in breast cancer.
Nan Wu, Lijuan Wei, Lijuan Li, Fangxuan Li, Jinpu Yu, Juntian Liu. Int J Clin Oncol 2022
0

Risk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency.
Annabelle G Hayes, R Louise Rushworth, David J Torpy. Expert Rev Endocrinol Metab 2022
1

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu. Gut 2022
2

Resistance Mechanisms to Anti-PD Cancer Immunotherapy.
Matthew D Vesely, Tianxiang Zhang, Lieping Chen. Annu Rev Immunol 2022
0

Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy.
Qiong Long, Peng Zheng, Xiao Zheng, Weiran Li, Liangqun Hua, Zhongqian Yang, Weiwei Huang, Yanbing Ma. Adv Drug Deliv Rev 2022
1

Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again.
Adrienne H Long, Daniel A Morgenstern, Amaury Leruste, Franck Bourdeaut, Kara L Davis. Am Soc Clin Oncol Educ Book 2022
0

Immune checkpoint inhibitors: Key trials and an emerging role in breast cancer.
Nicola Gaynor, John Crown, Denis M Collins. Semin Cancer Biol 2022
35

In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.
Zhi Li, Zewen K Tuong, Isaac Dean, Claire Willis, Fabrina Gaspal, Rémi Fiancette, Suaad Idris, Bethany Kennedy, John R Ferdinand, Ana Peñalver,[...]. J Exp Med 2022
0

Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
Jay Ponto, R Bryan Bell. Oral Maxillofac Surg Clin North Am 2022
0

Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.
Tae Kon Kim, Esten N Vandsemb, Roy S Herbst, Lieping Chen. Nat Rev Drug Discov 2022
0

Antigen Receptor T Cells (CAR-T) Effectively Control Tumor Growth in a Colorectal Liver Metastasis Model.
Louis F Chai, John C Hardaway, Kara R Heatherton, Kyle P O'Connell, Jason P LaPorte, Prajna Guha, Mikayla C Lopes, Benjamin A Rabinowitz, David Jaroch, Bryan F Cox,[...]. J Surg Res 2022
0

The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Cheng-Long Han, Guang-Xiao Meng, Zi-Niu Ding, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Lun-Jie Yan, Hui Liu, Bao-Wen Tian, Long-Shan Yang,[...]. Front Immunol 2022
0

Current Clinical Trial Landscape of OX40 Agonists.
Rashi Yadav, William L Redmond. Curr Oncol Rep 2022
1


Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease.
Parvez Khan, Jawed Akhtar Siddiqui, Shailendra Kumar Maurya, Imayavaramban Lakshmanan, Maneesh Jain, Apar Kishor Ganti, Ravi Salgia, Surinder Kumar Batra, Mohd Wasim Nasser. Semin Cancer Biol 2022
16